Non-Hodgkin lymphoma survivor Dan Dean spoke with several experts about the advances in genomic testing, which have enabled oncologists to treat patients with new “targeted therapies” that fight cancer based on the specific features of a tumor.

Until recently, the initial treatment for patients with CLL was chemotherapy alone. New targeted therapies are now available for use as the first treatment for CLL. At the 2019 ASCO meeting, 2 experts discussed the benefits of these new treatments.

“Lung cancer”—what first pops into your head when you hear that?

Cancer survivor Dan Dean weighs the many factors involved when deciding what to tell, or not tell, an employer about a cancer diagnosis and the job-related potential implications.

People affected by cancer find that dating requires a different playbook to navigate through relationships.

The long-term side effects of treatment can be an overlooked part of cancer care. "We're learning as they're surviving, and we can't assume we know everything," says Pam Simon, MSN.

Non-Hodgkin lymphoma survivor Dan Dean tackles the stigmas and difficulties associated with mental health diagnoses and therapies.

Survivorship can feel like a game of cancer whack-a-mole: pound one issue flat and another pops up, often where you weren’t even looking.